Evidence map›Paper›PMID 31386973›Full record

ArticleDrug and alcohol dependence2019

Patterns of nicotine concentrations in electronic cigarettes sold in the United States, 2013-2018.

Alexa R Romberg, Erin J Miller Lo, Alison F Cuccia, Jeffrey G Willett, Haijun Xiao, Elizabeth C Hair, Donna M Vallone, Kristy Marynak, Brian A King

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 4 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 4 syntheses or guidelines pooled it, 159 citations in OpenAlex.

  1. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Methods for Vaping Cessation Among Young Adults in Southern California.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  13. Article
  14. Chemical Analysis and Flavor Distribution of Electronic Cigarettes in Australian Schools.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Use of Cigarettes and E-Cigarettes, Impulsivity, and Anxiety: Influences on Suicidal Ideation Among Youth and Young Adults in Texas.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alexa R RombergTruth Initiative Schroeder Institute, 900 G Street NW, Washington, DC, 20001, USA. Electronic address: aromberg@truthinitiative.org.
Erin J Miller LoTruth Initiative Schroeder Institute, 900 G Street NW, Washington, DC, 20001, USA. Electronic address: elo@truthinitiative.org.
Alison F CucciaTruth Initiative Schroeder Institute, 900 G Street NW, Washington, DC, 20001, USA. Electronic address: acuccia@truthinitiative.org.
Jeffrey G WillettTruth Initiative Schroeder Institute, 900 G Street NW, Washington, DC, 20001, USA. Electronic address: jeff.willett@heart.org.
Haijun XiaoTruth Initiative Schroeder Institute, 900 G Street NW, Washington, DC, 20001, USA. Electronic address: jxiao@truthinitiative.org.
Elizabeth C HairTruth Initiative Schroeder Institute, 900 G Street NW, Washington, DC, 20001, USA. Electronic address: ehair@truthinitiative.org.
Donna M ValloneTruth Initiative Schroeder Institute, 900 G Street NW, Washington, DC, 20001, USA. Electronic address: dvallone@truthinitiative.org.
Kristy MarynakOffice on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1600 Clifton Road Atlanta, GA, 30329, USA. Electronic address: vhy4@cdc.gov.
Brian A KingOffice on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1600 Clifton Road Atlanta, GA, 30329, USA. Electronic address: baking@cdc.gov.
American Legacy Foundation · USNational Center for Chronic Disease Prevention and Health Promotion · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

introductionConsiderable declines in cigarette smoking have occurred in the U.S. over the past half century. Yet emerging tobacco products, including e-cigarettes, have increased in popularity among U.S. youth and adults in recent years. Nicotine content is an important factor in weighing the potential benefits and risks of e-cigarettes on individual and population level health. This study examined how nicotine concentrations of e-cigarette products sold have changed from 2013 to 2018.

methodsE-cigarette sales data aggregated in 4-week periods from March 2, 2013 to September 8, 2018 (66 months total) from convenience store and mass market channels were obtained from Nielsen. Internet and vape shop sales were not available. Internet searches were used to supplement information for nicotine concentration and flavor. Products were categorized by nicotine concentration, flavor, type (disposable or rechargeable), and brand. Dollar sales, unit sales, and average nicotine concentration were assessed.

resultsDuring 2013-2018, the average nicotine concentration in e-cigarettes sold increased overall, for all flavor categories, and for rechargeable e-cigarettes. The proportion of total dollar sales comprised of higher nicotine concentration e-cigarettes (>4% mg/mL) increased from 12.3% to 74.7% during 2013-2018, with a similar increase in unit share. Zero-nicotine products accounted for less than 1% of dollar market share across all years analyzed.

conclusionsE-cigarettes with higher nicotine concentrations comprise a substantial and increasing portion of U.S. e-cigarette sales. Higher nicotine concentrations may influence patterns of e-cigarette use, including harms from e-cigarette initiation among youth and potential health benefits for adult smokers switching completely to e-cigarettes.

Indexed as

CommerceElectronic Nicotine Delivery SystemsFlavoring AgentsHumansNicotineTobacco ProductsUnited StatesFlavoring AgentsNicotineE-cigarettesFlavorsNielsenSales

Identifiers

PMID31386973
PMCPMC6765364
OpenAlexW2962921611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.